Class information for:
Level 1: HBV REACTIVATION//HEPATITIS B VIRUS REACTIVATION//HEPATITIS B REACTIVATION

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
12238 857 33.5 87%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
124 23152 HEPATITIS B VIRUS//CHRONIC HEPATITIS B//HEPATITIS B

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 HBV REACTIVATION Author keyword 90 80% 7% 56
2 HEPATITIS B VIRUS REACTIVATION Author keyword 70 87% 4% 34
3 HEPATITIS B REACTIVATION Author keyword 36 77% 3% 24
4 REVERSE SEROCONVERSION Author keyword 33 100% 2% 13
5 ADOPTIVE IMMUNITY TRANSFER Author keyword 6 80% 0% 4
6 HCV REACTIVATION Author keyword 4 75% 0% 3
7 IMMUNOSUPPRESSIVE DISEASES Author keyword 3 100% 0% 3
8 HEPATITIS B VIRUS SCREENING Author keyword 2 67% 0% 2
9 ONCO HEMATOLOGICAL DISEASES Author keyword 2 67% 0% 2
10 SCDU GASTROENTEROL HEPATOL Address 2 67% 0% 2

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class		 LCSH search Wikipedia search
1 HBV REACTIVATION 90 80% 7% 56 Search HBV+REACTIVATION Search HBV+REACTIVATION
2 HEPATITIS B VIRUS REACTIVATION 70 87% 4% 34 Search HEPATITIS+B+VIRUS+REACTIVATION Search HEPATITIS+B+VIRUS+REACTIVATION
3 HEPATITIS B REACTIVATION 36 77% 3% 24 Search HEPATITIS+B+REACTIVATION Search HEPATITIS+B+REACTIVATION
4 REVERSE SEROCONVERSION 33 100% 2% 13 Search REVERSE+SEROCONVERSION Search REVERSE+SEROCONVERSION
5 ADOPTIVE IMMUNITY TRANSFER 6 80% 0% 4 Search ADOPTIVE+IMMUNITY+TRANSFER Search ADOPTIVE+IMMUNITY+TRANSFER
6 HCV REACTIVATION 4 75% 0% 3 Search HCV+REACTIVATION Search HCV+REACTIVATION
7 IMMUNOSUPPRESSIVE DISEASES 3 100% 0% 3 Search IMMUNOSUPPRESSIVE+DISEASES Search IMMUNOSUPPRESSIVE+DISEASES
8 HEPATITIS B VIRUS SCREENING 2 67% 0% 2 Search HEPATITIS+B+VIRUS+SCREENING Search HEPATITIS+B+VIRUS+SCREENING
9 ONCO HEMATOLOGICAL DISEASES 2 67% 0% 2 Search ONCO+HEMATOLOGICAL+DISEASES Search ONCO+HEMATOLOGICAL+DISEASES
10 VIRAL REACTIVATION 2 14% 1% 12 Search VIRAL+REACTIVATION Search VIRAL+REACTIVATION

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 HBV REACTIVATION 160 84% 10% 88
2 CYTOTOXIC CHEMOTHERAPY 115 48% 21% 176
3 PREEMPTIVE LAMIVUDINE 81 81% 6% 48
4 REVERSE SEROCONVERSION 79 94% 3% 29
5 VIRUS HBV REACTIVATION 49 79% 4% 31
6 VIRUS REACTIVATION 47 53% 7% 63
7 FATAL REACTIVATION 45 90% 2% 19
8 RECEIVING CYTOTOXIC CHEMOTHERAPY 41 85% 3% 22
9 DNA VIRAL LOAD 41 87% 2% 20
10 PROPHYLACTIC LAMIVUDINE 24 82% 2% 14

Journals

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
Recent US Food and Drug Administration Warnings on Hepatitis B Reactivation With Immune-Suppressing and Anticancer Drugs: Just the Tip of the Iceberg? 2015 3 18 61%
Management of patients with hepatitis B who require immunosuppressive therapy 2014 11 83 64%
Systematic review: The effect of preventive lamivudine on hepatitis B reactivation during chemotherapy 2008 171 31 74%
Reactivation of hepatitis B virus and hepatitis C virus in patients with cancer 2012 35 78 78%
Screening, prevention and treatment of viral hepatitis B reactivation in patients with haematological malignancies 2007 157 92 66%
Diagnosis, prevention and management of hepatitis B virus reactivation during anticancer therapy 2006 242 113 67%
Immunosuppression and HBV Reactivation 2013 17 83 63%
Hepatitis reactivation in patients with rheumatic diseases after immunosuppressive therapy-a report of long-term follow-up of serial cases and literature review 2014 3 36 86%
Lamivudine prevents reactivation of hepatitis B and reduces mortality in immunosuppressed patients: systematic review and meta-analysis 2008 70 62 76%
How I treat and monitor viral hepatitis B infection in patients receiving intensive immunosuppressive therapies or undergoing hematopoietic stem cell transplantation 2009 57 85 73%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ.
in class
1 SCDU GASTROENTEROL HEPATOL 2 67% 0.2% 2
2 AO SAN CAMILLO FORLANINI 1 50% 0.2% 2
3 DIGEST LIVER DIS DPT 1 100% 0.2% 2
4 IMPERIAL ORCHARD MED OFF 1 100% 0.2% 2
5 HEPATOBILLIARY ONCOL 1 40% 0.2% 2
6 ZHONGSHAN CITY PEOPLES HOSP 1 40% 0.2% 2
7 AFFLILIATED TUMOR HOSP 1 50% 0.1% 1
8 B PROPAEDEUT INTERNAL MED 1 50% 0.1% 1
9 BLOOD TRANSFUS HEMOPHILIA 2 1 50% 0.1% 1
10 CA GRANDE OSPED MAGGIORE POLICLIN 1 50% 0.1% 1

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000153952 HEPATITIS B IMMUNOGLOBULIN//HBIG//HEPATITIS B RECURRENCE
2 0.0000147705 OCCULT HBV INFECTION//ANTI HBC//OCCULT HEPATITIS B VIRUS INFECTION
3 0.0000123457 CHRONIC HEPATITIS B//ENTECAVIR//LAMIVUDINE
4 0.0000111566 FUNDACIO RECERCA MUTUA TERRASSA//INCUMBENT LAURA WARZ KIP CHAIR AUTOIMMUNE//AUTOIMMUNE INFLAMMATORY SYNDROME INDUCED BY ADJUVANTS
5 0.0000093522 CRYOGLOBULINEMIA//MIXED CRYOGLOBULINEMIA//CRYOGLOBULINAEMIA
6 0.0000079401 BENAVIDES CANC//COLORECTOANAL SURG//HEPATITIS A ACUTE
7 0.0000078186 DEFIBROTIDE//VENO OCCLUSIVE DISEASE//HEPATIC VENO OCCLUSIVE DISEASE
8 0.0000075410 PATHOGENESE VIRUS HEPATITE B//WOODCHUCK HEPATITIS VIRUS//WOODCHUCK
9 0.0000075279 POOR SEROCONVERSION//VACCINE CHILD HLTH//ABT EPIDEMIOL INFEKTIONSKRANKHEITEN
10 0.0000071122 IGM ANTI HBC//ANTI HBC IGM//HBVDNA